Gabriele Bergers
scientist
medical science
Flanders Interuniversity Institute for Biotechnology
Belgium
Biography
PhD: Univ. of Vienna and IMP, Austria, 1993 Research Scientist: Univ. of California, San Francisco, USA, 1994-01 Assistant/Associate Professor: Univ. of California, San Francisco, USA, 2001-05/2005-10 Professor: Univ. of California, San Francisco, USA, 2010-16 Adjunct Professor: Univ. of California, San Francisco, USA, 2016-present VIB Group leader since August 2016
Research Interest
PhD: Univ. of Vienna and IMP, Austria, 1993 Research Scientist: Univ. of California, San Francisco, USA, 1994-01 Assistant/Associate Professor: Univ. of California, San Francisco, USA, 2001-05/2005-10 Professor: Univ. of California, San Francisco, USA, 2010-16 Adjunct Professor: Univ. of California, San Francisco, USA, 2016-present VIB Group leader since August 2016
Publications
-
Glioblastoma: Defining Tumor Niches Hambardzumyan D, Bergers GTRENDS CANCER, 1, 252-265, 2015
-
Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy Rivera L, Meyronet D, Hervieu V, Frederick M, Bergsland E, Bergers GCell Reports, 11, 577-91, 2015
-
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation Allen E* Jabouille A* Rivera L Lodewijckx I Missiaen R Steri V Feyen K Tawney J Hanahan D Michael I Bergers GScience Translational Medicine, 9, eaak9679, 2017
